Search Results 6581-6590 of 37558 for oral
No medical condition that could interfere with oral medication intake (e.g., frequent vomiting or partial bowel obstruction); No other prior malignancies ...
... oral drug intake; No other malignancy within the past 5 years except nonmelanoma skin cancer, carcinoma in situ of the cervix, or ductal carcinoma in situ of ...
Niraparib is an oral poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) 1/2 inhibitor that has shown clinical activity in patients with ovarian cancer.
Topical skin steroid treatment, non-absorbable oral steroid treatment for GI GVHD, and resumption of GVHD prophylaxis agents (e.g., calcineurin inhibitors) are ...
Professional memberships. 2019 - present. Oral ExaminerAmerican Board of Otolaryngology. 2016 - present. MemberClinical Competency Committee, Residency Program ...
2013. ICMS Presentation day: Prize for best oral presentationImperial College, London, UK. 2013. Clinical Research Training FellowshipBritish Heart Foundation.
... oral immunomodulators[AAM2]. Adults between 18-80 years of age. Ability to provide informed consent. Ability to understand English either personally or ...
Acceptable methods are surgical sterilization, hormonal methods such as oral contraceptives, Norplant and Depo-Provera, double barrier method such as a condom ...
Fabrication of custom oral positioning devices in head and neck proton radiotherapy. J Prosthodont. 2023 Jul; 32 (6):546-550 Epub 2023 Apr 13. View PubMed; Hu ...
Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!